News

29.08.2016 – A new medical product named Pharmciclovir VIVA PHARM in the form of a film-coated tablets with dosage units of 125mg, and 250mg was registered by the order of a Chairman of the Control over medical and pharmaceutical activity Committee of the Ministry of health and social development of the Republic of Kazakhstan. Pharmciclovir VIVA PHARM is produced by the National manufacturer VIVA PHARM LLC. Registration ID numbers are РК-ЛС-3№022356 and РК-ЛС-3№022357 correspondingly to dosage units. 

Pharmciclovir VIVA PHARM is recommended for treatment of such diseases as, zona serpiginosa, genital herpes, infections, affected by Herpes simplex and Varicella zoster viruses.

Pharmciclovir VIVA PHARM has a quick onset of action, high bioavailability, proven effectiveness and security, and has no cumulative influence on organism.